Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Change in Receivables (2010 - 2025)

Palatin Technologies' (PTN) quarterly Change in Receivables came in at -$5.3 million in Q4 2025, down 176.24% quarter-over-quarter from $6.9 million in Q3 2025.

Analysis

Palatin Technologies (PTN) Change in Receivables (2010 - 2025) Analysis & Trends

Palatin Technologies (PTN) has reported Change in Receivables for 13 consecutive years, with -$5.3 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Change in Receivables changed N/A year-over-year to -$5.3 million; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (up 169.74% YoY), and the FY2024 full-year result was -$2.9 million, down 156.73% from the prior year.
  • Change in Receivables eased to -$5.3 million in Q4 2025 per PTN's latest filing, from $6.9 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $6.9 million in Q3 2025 and bottomed at -$5.3 million in Q4 2025.
  • Historically, Change in Receivables has averaged -$98728.8 across 5 years, with a median of $107880.0 in 2023.
  • The sharpest annual moves came in 2023 and 2024: Change in Receivables soared 745.68% in 2023, then sank 2274.79% in 2024.
  • Over 5 years, Change in Receivables stood at -$1.7 million in 2021, then surged by 112.98% to $215760.0 in 2022, then tumbled by 1090.39% to -$2.1 million in 2023, then slipped by 9.8% to -$2.3 million in 2024, then sank by 123.77% to -$5.3 million in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods registered -$5.3 million, $6.9 million, and -$2.3 million for Q4 2025, Q3 2025, and Q1 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 1.09 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 333.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 140.20 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 838.50 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -53.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 31.60 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 269.40 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Palatin Technologies 46.98 Mn 46.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -5.25 Mn
Sep 30, 2025 6.89 Mn
Mar 31, 2024 -2.35 Mn
Dec 31, 2023 -2.14 Mn
Sep 30, 2023 1.57 Mn
Jun 30, 2023 -1.22 Mn
Mar 31, 2023 107,880.00
Dec 31, 2022 215,760.00
Sep 30, 2022 -242,730.00
Jun 30, 2022 590,861.00
Mar 31, 2022 206,014.00
Dec 31, 2021 -1.66 Mn
Sep 30, 2021 666,428.00
Jun 30, 2021 3.45 Mn
Mar 31, 2021 -2.32 Mn
Dec 31, 2020 1.19 Mn
Sep 30, 2020 -744,372.00
Jun 30, 2020 120.53 Mn
Mar 31, 2020 -117,989.00
Dec 31, 2019 20,610.00